Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
CR
Corvel Corp
CRVL
Mkt Cap
$4.02B
Volume
118.52K
Next Earnings
November 3rd
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
CR
CRVL
CR
Corvel Corp
CRVL
News
·
CorVel (CRVL) Q4 2026 Earnings Call Transcript
Mkt Cap
$4.06B
Volume
118.52K
Next Earnings
November 3rd
Chart
Financials
Earnings
News
About
Insider
Filings
CorVel (CRVL) Q4 2026 Earnings Call Transcript
CorVel reported Q4 2026 earnings with quarterly revenue of $249 million (7% YoY increase) and EPS of $0.61 (up 19.6%). Full-year revenue reached $959 million with EPS of $2.14 (17% increase). The company secured multiyear contracts with top national payers, achieved 56% YoY growth in new bookings, and expanded RFP activity by 20%. Network Solutions delivered double-digit growth while Patient Management showed low single-digit growth. Management emphasized investments in AI, automation, and platform integration to enhance scalability.
The Motley Fool · May 20, 2026
CorVel (CRVL) Q3 2026 Earnings Call Transcript
CorVel reported Q3 2026 results with modest growth: revenue of $236 million (up 3% YoY) and EPS of $0.47 (up 2% YoY). The company highlighted strong operational metrics including 100% net revenue retention, 44% new business close rate, and meaningful AI-driven efficiency gains. Management attributed the modest results to short-term operational factors and tax normalization rather than fundamental business changes. The CERES division showed strong momentum in healthcare payment integrity services, with accelerated technology integration from a June acquisition. CorVel maintains a strong balance sheet with $230 million in cash, no debt, and continues share repurchases.
The Motley Fool · Feb 3, 2026
CorVel (CRVL) Q2 2026 Earnings Call Transcript
CorVel reported Q2 2026 financial results with $240 million revenue, a 7% increase from the previous year. The company highlighted significant investments in Agentic AI technology, workforce development through CorVel University, and strategic efforts to address labor market challenges in workers' compensation.
The Motley Fool · Nov 4, 2025
CorVel Announces Effectiveness of Three-For-One Forward Stock Split
CorVel Corporation announced a three-for-one forward stock split, effective December 24, 2024. The additional shares will be distributed on the same date, and trading is expected to begin on a post-split basis on December 26, 2024.
GlobeNewswire Inc. · Dec 24, 2024
CORXEL Acquires Worldwide (excluding Greater China) Rights to an Oral Small Molecule GLP-1 RA for the Treatment of Obesity and Diabetes
CORXEL, a biotech company, has acquired the worldwide (excluding Greater China) rights to CX11, an oral small molecule GLP-1 receptor agonist, for the treatment of obesity and diabetes. CX11 has shown promising results in a Phase 2 clinical trial conducted in China and CORXEL plans to initiate a global Phase 2 study in 2025.
Benzinga · Dec 23, 2024
CorVel Announces Retirement of V. Gordon Clemons
CorVel Corporation announces the retirement of its founder and Chairman, V. Gordon Clemons, after 37 years of service. Michael G. Combs, the company's President and CEO, will succeed Clemons as the new Chairman.
GlobeNewswire Inc. · Nov 29, 2024
Corstar Holdings Inc sells Corvel Corp shares worth over $12.9 million - Investing.com
Corstar Holdings Inc, a significant shareholder in Corvel Corp, has sold over $12.9 million worth of Corvel Corp shares between July 12 and July 16. The transactions were made pursuant to a Rule 10b5-1 trading plan.
Investing.com · Jul 17, 2024
CorVel Recent Insider Activity - Benzinga
CorVel, a healthcare technology company, reported insider selling activity. The company has shown positive revenue growth, strong earnings per share, and prudent debt management, but its valuation metrics suggest it may be overpriced.
Benzinga · Jul 11, 2024
CorVel Announces Revenues and Earnings
FORT WORTH, Texas, May 22, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter and fiscal year ended March 31, 2024. Revenues for the quarter were $207 million, an increase from $185 million in the same quarter of the previous year. Earnings per share for the quarter were $1.12, compared to $1.04 in the same quarter of the prior year.
GlobeNewswire Inc. · May 22, 2024
CorVel Announces New Integrations for Managed Care Services Enabling Partners to Increase Connectivity and Create a Seamless Workflow Experience
CorVel (NASDAQ: CRVL) unveils AI-driven managed care solutions, offering seamless integration and enhanced insights for partners, improving patient care.
GlobeNewswire Inc. · Apr 23, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
CR
CRVL
Corvel Corp
Buy
Sell
Market
Limit
Soon
CRVL
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any CRVL yet.
Related Tickers
Earnings